
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+8
AMCo is a rapidly-growing international pharmaceutical company. We supply niche medicines that make a real difference to the patients, doctors, hospitals and healthcare authorities we serve in over 100 countries worldwide. We are building our portfolio of global niche medicines through acquisition, in-licensing and internal developments. AMCo is the result of a merger of Amdipharm and the Mercury Pharma Group in 2013. We have since acquired a number of other pharma companies and medicines. Our most recent company acquisitions are the Focus Group, based in the UK, and Abcur AB, based in Sweden. Our most recent product acquisition is Fucithalmic...
Pharmaceuticals,endocrinology,medicines,ophthalmology,anti-infective,pain & inflammation,neurological disorders,levothyroxine,nitrofurantoin,fusidic acid,prednisolone,carbimazole,and urology
Amco (formerly amdipharm mercury ltd) operates in the Pharmaceutical manufacturing industry.
Amco (formerly amdipharm mercury ltd)'s revenue is 11m - 100m
Amco (formerly amdipharm mercury ltd) has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.